The Office of the Attorney General necessary Minister of Health j Social protection, Guillermo Alfonso Jaramillo Martinez to take urgent and effective measures to ensure the availability of medicines to treat the chronic disease hepatitis C.
In return, the State Ministry requested the Administrator of Resources of the General Health and Social Security System (ADRES) to continue the procedures for the direct purchase of the EPCLUSA drug, which is why this was also the subject of a request from the institution. Control of the last days to indicate the corrective actions taken.
According to the law, the Ministry’s duties include the procurement of pharmaceutical products through the system of “Central shopping” However, the delay in procedures endangers the health of citizens suffering from this costly chronic disease.
The Attorney General’s Office received a report indicating that in 2023 there were shortages in the supply of medicines to the EPS, preventing the start of timely treatment for the hundreds of people suffering from this scourge.
Drug management with cost optimization is also the responsibility of the Minister’s decisions; However, price negotiations and commercial strategies do not excuse the failure to guarantee Colombians’ fundamental right to health.
The company is currently conducting disciplinary action to investigate the shortage of this and other drugs in the country.
